Hasegawa M, Fujimoto M, Kikuchi K, Takehara K
Department of Dermatology, Kanazawa University School of Medicine, Japan.
J Rheumatol. 1997 Apr;24(4):663-5.
To determine whether serum tumor necrosis factor-alpha (TNF-alpha) levels are elevated, and whether they correlate with clinical features in patients with systemic sclerosis (SSc).
Serum samples from patients with limited cutaneous SSc (ISSc) (n = 51), diffuse cutaneous SSc (dSSc) (n = 30), and control subjects (n = 30) were examined by ELISA.
Serum TNF-alpha levels were elevated in patients with ISSc and dSSc and correlated with the presence of pulmonary fibrosis and with the decreased vital capacity of the patients.
Serum TNF-alpha may be one of the cytokines that contribute to the disease process, especially to pulmonary fibrosis in patients with SSc.
确定系统性硬化症(SSc)患者血清肿瘤坏死因子-α(TNF-α)水平是否升高,以及这些水平是否与临床特征相关。
采用酶联免疫吸附测定法(ELISA)检测局限性皮肤型SSc(lSSc)患者(n = 51)、弥漫性皮肤型SSc(dSSc)患者(n = 30)及对照受试者(n = 30)的血清样本。
lSSc和dSSc患者的血清TNF-α水平升高,且与肺纤维化的存在以及患者肺活量降低相关。
血清TNF-α可能是导致疾病进程,尤其是SSc患者肺纤维化的细胞因子之一。